CGT
ALXN

Capital Guardian Trust’s Alexion Pharmaceuticals ALXN Stock Holding History

Capital Guardian Trust’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-398
Closed -$55K – 495
2018
Q3 		$55K Buy
+398
New +$49.9K ﹤0.01% 329
2017
Q2 		– Sell
-50
Closed -$6K – 598
2017
Q1 		$6K Hold
50
– – ﹤0.01% 577
2016
Q4 		$6K Hold
50
– – ﹤0.01% 619
2016
Q3 		$6K Hold
50
– – ﹤0.01% 626
2016
Q2 		$6K Hold
50
– – ﹤0.01% 601
2016
Q1 		$7K Sell
50
-201
-80% -$29.5K ﹤0.01% 651
2015
Q4 		$48K Hold
251
– – ﹤0.01% 458
2015
Q3 		$39K Hold
251
– – ﹤0.01% 453
2015
Q2 		$45K Hold
251
– – ﹤0.01% 452
2015
Q1 		$43K Hold
251
– – ﹤0.01% 465
2014
Q4 		$46K Hold
251
– – ﹤0.01% 411
2014
Q3 		$42K Hold
251
– – ﹤0.01% 411
2014
Q2 		$39K Buy
251
+50
+25% +$7.89K ﹤0.01% 404
2014
Q1 		$31K Sell
201
-14
-7% -$2.23K ﹤0.01% 408
2013
Q4 		$29K Hold
215
– – ﹤0.01% 417
2013
Q3 		$25K Hold
215
– – ﹤0.01% 392
2013
Q2 		$20K Buy
+215
New +$20.7K ﹤0.01% 390

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return